Crizotinib/gefitinibDevelopment of resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1676卷 / 1期

关键词：

D O I：

10.1007/s40278-017-38095-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：107 / 107

相关论文

共 50 条

[31] Crizotinib/erlotinibDrug resistance, vomiting and rash: case report
Reactions Weekly, 2017, 1678 (1) : 66 - 66
[32] Crizotinib/icotinibDrug resistance and various toxicities: case report
Reactions Weekly, 2019, 1781 (1) : 122 - 122
[33] Crizotinib/gefitinib/osimertinibDrug resistance and rash: case report
Reactions Weekly, 2019, 1763 (1) : 117 - 117
[34] Crizotinib/pemetrexedAcquired drug resistance and neutropenia: case report
Reactions Weekly, 2015, 1555 (1) : 66 - 66
[35] Crizotinib/nivolumab/tepotinibNausea and drug resistance: case report
Reactions Weekly, 2021, 1877 (1) : 122 - 122
[36] Crizotinib/gefitinib/osimertinibEmergence of drug resistance: case report
Reactions Weekly, 2021, 1873 (1) : 86 - 86
[37] GefitinibDevelopment of gefitinib resistance in stage IV squamous cell lung cancer: case report
Reactions Weekly, 2018, 1696 (1) : 172 - 172
[38] GefitinibDevelopment of resistance in lung adenocarcinoma transforming to small cell lung cancer: case report
Reactions Weekly, 2017, 1659 (1) : 135 - 135
[39] Erlotinib/gefitinibDevelopment of resistance to first generation EGFR tyrosine kinase inhibitors: case report
Reactions Weekly, 2015, 1566 (1) : 99 - 99
[40] GefitinibDevelopment of drug resistance in non-small-cell lung cancer: case report
Reactions Weekly, 2019, 1763 (1) : 169 - 169

← 1 2 3 4 5 →